 BetterLife Pharma Inc CSE:BETR, OTCQB:BETRF announced that it has obtained the first set of behavioral animal pharmacology data for its lead compound, 2-bromo-LSD TD-0148A, in collaboration with the University of California San Diego UCSD laboratory, led by Dr. Adam L. 